Neurostimulation Devices Market Trends, 2020-2025 - Global Market Expected to Reach $9.6 Billion by 2025 - ResearchAndMarkets.com

DUBLIN--()--The "Neurostimulation Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.

The global neurostimulation devices market reached a value of US$ 5.5 Billion in 2019. Looking forward, the market is expected to reach a value of US$ 9.6 Billion by 2025, registering a CAGR of 9.5% during 2020-2025.

The rising instances of neurological and lifestyle-related disorders, along with the rapidly growing geriatric population across the globe, are among the key factors driving the growth of the market.

Furthermore, the increasing preference for minimally invasive (MI) procedures among patients is also providing a boost to the market growth. For instance, deep brain stimulation (DBS) is an MI procedure that uses neurostimulation devices to deliver electrical signals to a specific spot in the brain circuits. This aids in treating various degenerative disorders, such as Parkinson's and Alzheimer's disease.

Additionally, technological advancements, including the development of devices that can electronically stimulate the nervous system to restore vision and regain post-paralysis motor movements, are creating a positive outlook for the market. Other factors, including significant growth in the medical industry, increasing healthcare expenditure and extensive research and development (R&D) activities, are projected to drive the market in the upcoming years.

The competitive landscape of the industry has also been examined with some of the key players being Biocontrol Medical, Boston Scientific Corporation, Cyberonics Inc., Medtronic Inc., Neuronetics Inc., Neuropace Inc., Neurosigma Inc., Nevro Corporation, ST. Jude Medical Inc., Synapse Biomedical Inc., etc.

Key Questions Answered

  • How has the global neurostimulation devices market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the stimulation type?
  • What is the breakup of the market based on the device type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the market?
  • What is the structure of the global neurostimulation devices market and who are the key players?
  • What is the degree of competition in the market?

Key Topics Covered

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Neurostimulation Devices Market

5.1 Market Overview

5.2 Market Performance

5.3 Market Forecast

6 Market Breakup by Stimulation Type

6.1 Internal Stimulation

6.2 External Stimulation

7 Market Breakup by Device Type

7.1 SCS (Spinal Cord Stimulation) Devices

7.2 DBS (Deep Brain Stimulation) Devices

7.3 SNS (Sacral Nerve Stimulation) Devices

7.4 VNS (Vagus Nerve Stimulation) Devices

7.5 GES (Gastric Electrical Stimulation) Devices

7.6 Transcutaneous Electrical Nerve Stimulation Devices

7.7 Transcranial Magnetic Stimulation Devices

7.8 Others

8 Market Breakup by Application

8.1 Pain Management

8.2 Epilepsy

8.3 Essential Tremors

8.4 Urinary and Fecal Incontinence

8.5 Depression

8.6 Dystonia

8.7 Parkinson's Disease

8.8 Others

9 Market Breakup by End-User

9.1 Rehabilitation Centers

9.2 Hospitals

9.3 Medical Clinics

9.4 Others

10 Market Breakup by Region

10.1 North America

10.2 Europe

10.3 Asia Pacific

10.4 Latin America

10.5 Middle East and Africa

11 SWOT Analysis

11.1 Overview

11.2 Strengths

11.3 Weaknesses

11.4 Opportunities

11.5 Threats

12 Value Chain Analysis

12.1 Overview

12.2 Inbound Logistics

12.3 Operations

12.4 Outbound Logistics

12.5 Marketing and Sales

12.6 Post Sales Services

13 Porters Five Forces Analysis

13.1 Overview

13.2 Bargaining Power of Buyers

13.3 Bargaining Power of Suppliers

13.4 Degree of Competition

13.5 Threat of New Entrants

13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

15.1 Market Structure

15.2 Key Players

15.3 Profiles of Key Players

15.3.1 Biocontrol Medical

15.3.1.1 Company Overview

15.3.1.2 Product Portfolio

15.3.2 Boston Scientific Corporation

15.3.3 Cyberonics Inc.

15.3.4 Medtronic Inc.

15.3.5 Neuronetics Inc.

15.3.6 Neuropace Inc.

15.3.7 Neurosigma Inc.

15.3.8 Nevro Corporation

15.3.9 St. Jude Medical Inc.

15.3.10 Synapse Biomedical Inc.

For more information about this report visit https://www.researchandmarkets.com/r/rd6h63

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900